Table of Content

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Treatment Type
3.2. Snippet by Route of Administration
3.3. Snippet by Distribution Channel
3.4. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Increasing incidence of monkeypox cases
4.1.2. Restraints
4.1.2.1. High costs associated with drugs and vaccines
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter’s Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Reimbursement Analysis
5.6. Patent Analysis
5.7. SWOT Analysis
5.8. Pipeline Analysis
5.9. DMI Opinion
6. By Treatment Type
6.1. Introduction
6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
6.1.2. Market Attractiveness Index, By Treatment Type
6.2. Vaccine Type*
6.2.1. Introduction
6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.2.3. JYNNEOS (Imvanex)
6.2.4. LC16-KMB
6.2.5. ACAM2000
6.2.6. OrthopoxVac
6.2.7. Others
6.3. Drug Type
6.3.1. Antiviral Drugs*
6.3.1.1. Introduction
6.3.1.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3.1.3. Tecovirimat
6.3.1.4. Cidofovir
6.3.1.5. Brincidofovir
6.3.1.6. Vaccinia Immuneglobulin
6.3.1.7. Trifluridine
6.3.2. Antihistamine Drugs
6.3.2.1. Benadryl
6.3.2.2. Others
6.3.3. NSAIDs
6.3.3.1. Ibuprofen (Advil, Motrin)
6.3.3.2. Naproxen (Aleve)
6.3.3.3. Others
6.3.4. Topical Anesthetics
6.3.4.1. Lidocaine
6.3.4.2. Benzocaine
6.3.4.3. Others
6.3.5. Others
7. By Route of Administration
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Route of Administration
7.1.2. Market Attractiveness Index, By Route of Administration
7.2. Oral*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Topical
7.4. Parenteral
8. By Distribution Channel
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
8.1.2. Market Attractiveness Index, By Distribution Channel
8.2. Hospital Pharmacies*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Retail Pharmacies
8.4. Online Pharmacies
8.5. Others
9. By Region
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
9.1.2. Market Attractiveness Index, By Region
9.2. North America
9.2.1. Introduction
9.2.2. Key Region-Specific Dynamics
9.2.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
9.2.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Route of Administration
9.2.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.2.3.1. The U.S.
9.2.3.2. Canada
9.2.3.3. Mexico
9.3. Europe
9.3.1. Introduction
9.3.2. Key Region-Specific Dynamics
9.3.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
9.3.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Route of Administration
9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.3.4.1. Germany
9.3.4.2. UK
9.3.4.3. France
9.3.4.4. Italy
9.3.4.5. Spain
9.3.4.6. Rest of Europe
9.4. South America
9.4.1. Introduction
9.4.2. Key Region-Specific Dynamics
9.4.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
9.4.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Route of Administration
9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.4.4.1. Brazil
9.4.4.2. Argentina
9.4.4.3. Rest of South America
9.5. Asia-Pacific
9.5.1. Introduction
9.5.2. Key Region-Specific Dynamics
9.5.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
9.5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Route of Administration
9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.5.4.1. China
9.5.4.2. India
9.5.4.3. Japan
9.5.4.4. South Korea
9.5.4.5. Rest of Asia-Pacific
9.6. Middle East and Africa
9.6.1. Introduction
9.6.2. Key Region-Specific Dynamics
9.6.2.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Drug Class
9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
10. Competitive Landscape
10.1. Competitive Scenario
10.2. Market Positioning/Share Analysis
10.3. Mergers and Acquisitions Analysis
11. Company Profiles
11.1. Bavarian Nordic A/S*
11.1.1. Company Overview
11.1.2. Product Portfolio and Description
11.1.3. Financial Overview
11.1.4. Key Developments
11.2. Emergent BioSolutions Inc.
11.3. SIGA Technologies, Inc.
11.4. BASF Corporation
11.5. Wellona Pharma
11.6. Zuche Pharmaceuticals Private Limited
11.7. Sambria Pharmaceuticals
11.8. Sun Pharmaceutical Industries Ltd.
11.9. Pfizer Inc.
11.10. Teva Pharmaceuticals USA, Inc. (*LIST NOT EXHAUSTIVE)
12. Appendix
12.1. About Us and Services
12.2. Contact Us